todayonchain.com

AI in Healthcare? Pfizer, Anthropic, and Longevity Scientists Think It’s Critical

BeInCrypto
Pfizer, Anthropic, and longevity researchers are leveraging AI to accelerate drug discovery, enhance security, and potentially reverse the aging process.

Summary

Major industry players, including Pfizer, Anthropic, and leading longevity experts, identify AI as a transformative force in healthcare. Pfizer is currently reviewing AI-designed molecules to expedite drug development, while Anthropic CEO Dario Amodei highlights AI's role in identifying critical software vulnerabilities and maintaining a competitive edge in tech. Meanwhile, researchers like Aubrey de Grey and Derya Unutmaz suggest that AI breakthroughs could lead to the reversal of aging and the treatment of most diseases within the next decade, with some experts arguing that the use of AI in medical practice will soon become a standard requirement.

(Source:BeInCrypto)